Hyalmass Aqua-Exosome - Courtesy of Maypharm

Maypharm Unveils Hyalmass Aqua-Exosome

PUBLISHED ON

TEXT BY

READ MORE ABOUT

SHARE THIS ARTICLE

Maypharm Launches Innovative Hybrid Filler

Maypharm Co., Ltd., a leader in medical and cosmetic innovations, has announced the global release of Hyalmass Aqua-Exosome, a novel hybrid mesotherapy filler aimed at enhancing skin hydration and revitalization.

Revolutionizing the Aesthetic Industry

Maypharm Co., Ltd. is poised to transform the field of aesthetics with its latest product, Hyalmass Aqua-Exosome. This state-of-the-art hybrid filler merges the benefits of hyaluronic acid, exosomes, and PDRN, optimizing skin hydration, elasticity, and regeneration.

Don’t miss out on the latest news by signing up for our newsletters

By subscribing, you agree to our Terms of Use and Privacy Policy.

Related Articles

Banner Ads-02

No results found.

Use of our site constitutes acceptance of our:

Terms & Conditions  |  Privacy Policy  |  Disclaimer   |  Cookie Statement

©2024 WHATSNEW Media – All Right Reserved. Designed and Developed by DopamineMktg.com. 

WHATSNEW may earn a portion of sales from products that are purchased through our site as part of our Affiliate Partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WHATSNEW Media.

Whatsnew Logo made of black black letters

Sign up for our Newsletter today and receive the latest news directly to your mailbox

*By subscribing you agree to our User Agreement (including the class action waiver and arbitration provisions), our Privacy Policy & Cookie Statement and to receive marketing and account-related emails from WHATSNEW. You can unsubscribe at any time. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms & Conditions apply.

MEN

WOMEN

Email
WhatsApp
Telegram
Facebook
X
LinkedIn
Reddit
Pinterest
Threads
Skype
VK
OK
Tumblr
Digg
Mix
StumbleUpon
Pocket
XING

SORRY

Unfortunately you cannot ACCESS THIS ARTICLE OR PAGE as you are not of legal AGE.  

 

Test Pop up